Next Article in Journal
Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica
Next Article in Special Issue
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
Previous Article in Journal
Study and Characterization of Polyvinyl Alcohol-Based Formulations for 3D Printlets Obtained via Fused Deposition Modeling
Previous Article in Special Issue
Doxorubicin-Loaded Polymeric Micelles Conjugated with CKR- and EVQ-FLT3 Peptides for Cytotoxicity in Leukemic Stem Cells
 
 
Review

Article Versions Notes

Pharmaceutics 2023, 15(7), 1868; https://doi.org/10.3390/pharmaceutics15071868
Action Date Notes Link
article pdf uploaded. 2 July 2023 11:39 CEST Version of Record https://www.mdpi.com/1999-4923/15/7/1868/pdf-vor
article xml file uploaded 3 July 2023 06:05 CEST Original file -
article xml uploaded. 3 July 2023 06:05 CEST Update https://www.mdpi.com/1999-4923/15/7/1868/xml
article pdf uploaded. 3 July 2023 06:05 CEST Updated version of record https://www.mdpi.com/1999-4923/15/7/1868/pdf
article html file updated 3 July 2023 06:06 CEST Original file -
article html file updated 19 July 2023 20:20 CEST Update https://www.mdpi.com/1999-4923/15/7/1868/html
Back to TopTop